Case Study from MANAGEMENT 4:06pm

When expertise is applied in a new field

Novartis Logo

Chief information officer improved supply of drugs

©Bild Week in Review Jan 25, 2013

Week in Review, January 26

Novartis appoints a friendly German as Huawei pledges to open up

Jan 24, 2013

IBM develops gel to fight infections

Semiconductor science replicated to kill microbes

From LEX Jan 23, 2013

Novartis: change at the top

Vasella’s departure could be signal for overdue check-up

Jan 23, 2013

Novartis chairman leaves mixed legacy

Vasella’s expansionist strategy has drawn criticism

Daniel Vasella ©AFP/Getty Images Jan 23, 2013

Vasella to step down as Novartis chairman

Reinhardt to replace veteran who led Swiss group for 17 years

Jan 23, 2013

Allergan adds MAP to migraine plans

US maker of Botox in $958m deal for MAP Pharma

From HEALTH CARE Jan 22, 2013

J&J pledges growth for consumer business

Recalls have hit reputation of many of US company’s top brands

From WORLD Jan 20, 2013

Universities back venture capital fund

Three Scottish colleges pledge £6m to boost for life sciences

From RETAIL & CONSUMER Jan 18, 2013

Advert for e-cigarettes to be shown on TV

Cigarette advertising has been banned on British TV since 1965

Jan 18, 2013

Pfizer’s Zoetis IPO set to raise $2.2bn

Animal-health business could be valued at $12bn

From WORLD Jan 16, 2013

MPs warn on medicines pricing

Call for ‘value-based’ plans to be made public by March

Jan 15, 2013

AstraZeneca’s new chief shakes up top team

Reshuffle comes as Soriot tries to reinvigorate pharma group

From SPECIAL REPORTS Jan 15, 2013

Misery loves company

Using social media to track outbreaks of disease can provide valuable public health information

Jan 11, 2013

Worst flu outbreak in decade to cost $10bn

Epidemic puts pressure on hospitals and insurers

Jan 10, 2013

FDA examines pain pill formula regulation

Generics may be forced to adopt tamper-resistant technology

From LEX Jan 8, 2013

Global pharma: check that pulse

Patent cliff has been the industry’s excuse for a decade of underperformance

Jan 7, 2013

Roche abandons pursuit of Illumina

Swiss pharmaceutical group says acquisition deal is off the table

Jan 7, 2013

Sanofi unit acquires Rolaids from J&J

Antacid to be relaunched following withdrawal from market in 2010

From FINANCIALS Jan 4, 2013

Goldman seeks $7m legal costs from Gupta

Further claim likely for $35m advance

MOST POPULAR NOW ON FT.COM

COMPANIES NEWS ON TWITTER

More FT Twitter accounts